• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一款智能设备对中度年龄相关性黄斑变性患者进行12个月家庭监测的性能

Performance of a Smart Device over 12-Months for Home Monitoring of Patients with Intermediate Age-Related Macular Degeneration.

作者信息

Prea Selwyn, Guymer Robyn, Kong George, Vingrys Algis

机构信息

Department of Optometry and Vision Sciences, The University of Melbourne, Melbourne 3010, Australia.

Royal Victorian Eye and Ear Hospital, East Melbourne 3002, Australia.

出版信息

J Clin Med. 2023 Mar 27;12(7):2530. doi: 10.3390/jcm12072530.

DOI:10.3390/jcm12072530
PMID:37048613
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10095505/
Abstract

BACKGROUND

To determine the 12-month compliance with and retention of home monitoring (HM) with Melbourne Rapid Fields (MRFh) for patients with intermediate age-related macular degeneration (iAMD) and compare visual acuity (VA) and retinal sensitivity (RS) results to clinical measures.

METHODS

Participants were recruited to a 12-month HM study with weekly testing of vision with MRFh. Inclusion criteria were a diagnosis of iAMD, understand English instructions, VA ≥ 20/40, and access to an iPad. Supervised in-clinic testing of high contrast VA (HVA, ETDRS), low-luminance VA (LLVA, ETDRS with ND2 filter), and RS (Macular Integrity Assessment, MAIA, and MRF in-clinic, MRFc) was conducted every 6-months.

RESULTS

A total of 54 participants (67 ± 6.8 years) were enrolled. Compliance to weekly HM was 61% and study retention at 12-months was 50% of those with uptake ( = 46). No difference was observed between MRFc and MRFh across all RS and VA outcomes ( > 0.05). MRFh RS was higher than MAIA (29.1 vs. 27.1 dB, < 0.001). MRFh HVA was not different from ETDRS ( = 0.08), but LLVA was 9 letters better (81.5 vs. 72.4 letters, < 0.001).

CONCLUSIONS

Over 12-months, MRFh yields a moderate level of compliance with (61%) and retention (50%) of weekly testing. Further studies are required to assess the ability of MRFh to detect early progression to nAMD.

摘要

背景

确定中度年龄相关性黄斑变性(iAMD)患者使用墨尔本快速视野(MRFh)进行家庭监测(HM)的12个月依从性和保留率,并将视力(VA)和视网膜敏感度(RS)结果与临床测量结果进行比较。

方法

招募参与者进行为期12个月的HM研究,每周使用MRFh测试视力。纳入标准为iAMD诊断、理解英语说明、VA≥20/40以及能够使用iPad。每6个月进行一次高对比度VA(HVA,ETDRS)、低亮度VA(LLVA,带ND2滤镜的ETDRS)和RS(黄斑完整性评估,MAIA,以及临床内MRF,MRFc)的监督性临床测试。

结果

共招募了54名参与者(67±6.8岁)。每周HM的依从率为61%,12个月时的研究保留率为参与接受监测者的50%(n = 46)。在所有RS和VA结果中,MRFc和MRFh之间未观察到差异(P>0.05)。MRFh RS高于MAIA(29.1对27.1 dB,P<0.001)。MRFh HVA与ETDRS无差异(P = 0.08),但LLVA高9个字母(81.5对72.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9c9/10095505/1815e3ff89ef/jcm-12-02530-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9c9/10095505/e2e30c3a8462/jcm-12-02530-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9c9/10095505/dcd311babc77/jcm-12-02530-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9c9/10095505/07ee5659d51a/jcm-12-02530-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9c9/10095505/2d33ba61682a/jcm-12-02530-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9c9/10095505/e55417002401/jcm-12-02530-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9c9/10095505/1815e3ff89ef/jcm-12-02530-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9c9/10095505/e2e30c3a8462/jcm-12-02530-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9c9/10095505/dcd311babc77/jcm-12-02530-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9c9/10095505/07ee5659d51a/jcm-12-02530-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9c9/10095505/2d33ba61682a/jcm-12-02530-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9c9/10095505/e55417002401/jcm-12-02530-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9c9/10095505/1815e3ff89ef/jcm-12-02530-g006.jpg

相似文献

1
Performance of a Smart Device over 12-Months for Home Monitoring of Patients with Intermediate Age-Related Macular Degeneration.一款智能设备对中度年龄相关性黄斑变性患者进行12个月家庭监测的性能
J Clin Med. 2023 Mar 27;12(7):2530. doi: 10.3390/jcm12072530.
2
Test Reliability and Compliance to a Twelve-Month Visual Field Telemedicine Study in Glaucoma Patients.青光眼患者十二个月视野远程医疗研究的测试可靠性与依从性
J Clin Med. 2022 Jul 25;11(15):4317. doi: 10.3390/jcm11154317.
3
The Short-Term Compliance and Concordance to in Clinic Testing for Tablet-Based Home Monitoring in Age-Related Macular Degeneration.基于平板电脑的家庭监测在年龄相关性黄斑变性中的短期依从性和一致性的临床检测。
Am J Ophthalmol. 2022 Mar;235:280-290. doi: 10.1016/j.ajo.2021.09.003. Epub 2021 Sep 9.
4
Home Monitoring of Retinal Sensitivity on a Tablet Device in Intermediate Age-Related Macular Degeneration.使用平板设备对中度年龄相关性黄斑变性患者进行视网膜敏感度的家庭监测
Transl Vis Sci Technol. 2018 Oct 29;7(5):32. doi: 10.1167/tvst.7.5.32. eCollection 2018 Sep.
5
Longitudinal Evaluation of Visual Function Impairments in Early and Intermediate Age-Related Macular Degeneration Patients.早、中年年龄相关性黄斑变性患者视觉功能损害的纵向评估
Ophthalmol Sci. 2022 May 20;2(3):100173. doi: 10.1016/j.xops.2022.100173. eCollection 2022 Sep.
6
Focal electroretinogram and microperimetry testing of photoreceptor-retinal pigment epithelium function in intermediate age-related macular degeneration.中龄相关性黄斑变性的光感受器-视网膜色素上皮功能的焦点视网膜电图和微视野检查。
Acta Ophthalmol. 2022 May;100(3):277-284. doi: 10.1111/aos.14934. Epub 2021 Jun 29.
7
Detecting vision loss in intermediate age-related macular degeneration: A comparison of visual function tests.检测中老年相关性黄斑变性的视力丧失:视觉功能测试的比较。
PLoS One. 2020 Apr 16;15(4):e0231748. doi: 10.1371/journal.pone.0231748. eCollection 2020.
8
Real-World Effectiveness and Real-World Cost-Effectiveness of Intravitreal Aflibercept and Intravitreal Ranibizumab in Neovascular Age-Related Macular Degeneration: Systematic Review and Meta-Analysis of Real-World Studies.真实世界中抗 VEGF 药物治疗新生血管性年龄相关性黄斑变性的疗效和成本效果分析:真实世界研究的系统评价和荟萃分析。
Adv Ther. 2020 Jan;37(1):300-315. doi: 10.1007/s12325-019-01147-6. Epub 2019 Nov 14.
9
Visual Function Metrics in Early and Intermediate Dry Age-related Macular Degeneration for Use as Clinical Trial Endpoints.早期和中期干性年龄相关性黄斑变性的视觉功能指标作为临床试验终点的应用。
Am J Ophthalmol. 2018 May;189:127-138. doi: 10.1016/j.ajo.2018.02.012. Epub 2018 Mar 15.
10
Phase 1 Clinical Trial of Elamipretide in Intermediate Age-Related Macular Degeneration and High-Risk Drusen: ReCLAIM High-Risk Drusen Study.依拉米肽治疗中度年龄相关性黄斑变性和高危玻璃膜疣的1期临床试验:ReCLAIM高危玻璃膜疣研究
Ophthalmol Sci. 2021 Dec 22;2(1):100095. doi: 10.1016/j.xops.2021.100095. eCollection 2022 Mar.

引用本文的文献

1
Descriptive study of the challenges when implementing an app for patients with neovascular age-related macular degeneration to monitor their vision at home.描述性研究:实施一款用于在家中监测年龄相关性黄斑变性患者视力的应用程序时所面临的挑战。
BMJ Open. 2024 Mar 7;14(3):e077196. doi: 10.1136/bmjopen-2023-077196.
2
Evaluating the Efficacy of Teleophthalmology in Delivering Ophthalmic Care to Underserved Populations: A Literature Review.评估远程眼科在为服务不足人群提供眼科护理方面的效果:一项文献综述。
J Clin Med. 2023 Apr 27;12(9):3161. doi: 10.3390/jcm12093161.

本文引用的文献

1
Prospective, Longitudinal Pilot Study: Daily Self-Imaging with Patient-Operated Home OCT in Neovascular Age-Related Macular Degeneration.前瞻性纵向试点研究:在新生血管性年龄相关性黄斑变性患者中使用患者操作的家用光学相干断层扫描进行每日自我成像。
Ophthalmol Sci. 2021 Jun 26;1(2):100034. doi: 10.1016/j.xops.2021.100034. eCollection 2021 Jun.
2
Test Reliability and Compliance to a Twelve-Month Visual Field Telemedicine Study in Glaucoma Patients.青光眼患者十二个月视野远程医疗研究的测试可靠性与依从性
J Clin Med. 2022 Jul 25;11(15):4317. doi: 10.3390/jcm11154317.
3
Evaluation of the Melbourne Rapid Fields Test Procedure.
墨尔本快速现场测试程序评估。
Optom Vis Sci. 2022 Apr 1;99(4):372-382. doi: 10.1097/OPX.0000000000001889.
4
Glaucoma Screening Using an iPad-Based Visual Field Test in a West African Population.基于 iPad 的视野测试在西非人群中的青光眼筛查。
Ophthalmol Glaucoma. 2022 May-Jun;5(3):275-283. doi: 10.1016/j.ogla.2021.09.002. Epub 2021 Sep 17.
5
The Short-Term Compliance and Concordance to in Clinic Testing for Tablet-Based Home Monitoring in Age-Related Macular Degeneration.基于平板电脑的家庭监测在年龄相关性黄斑变性中的短期依从性和一致性的临床检测。
Am J Ophthalmol. 2022 Mar;235:280-290. doi: 10.1016/j.ajo.2021.09.003. Epub 2021 Sep 9.
6
Real-World Performance of a Self-Operated Home Monitoring System for Early Detection of Neovascular Age-Related Macular Degeneration.用于早期检测新生血管性年龄相关性黄斑变性的自主式家庭监测系统的真实世界性能
J Clin Med. 2021 Mar 25;10(7):1355. doi: 10.3390/jcm10071355.
7
Home Monitoring of Age-Related Macular Degeneration: Utility of the ForeseeHome Device for Detection of Neovascularization.年龄相关性黄斑变性的家庭监测:ForeseeHome 设备用于检测新生血管的效用。
Ophthalmol Retina. 2021 Apr;5(4):348-356. doi: 10.1016/j.oret.2020.08.003. Epub 2020 Aug 15.
8
Measuring Virtual Reality Headset Resolution and Field of View: Implications for Vision Care Applications.测量虚拟现实头盔分辨率和视野:对视光应用的影响。
Optom Vis Sci. 2020 Aug;97(8):573-582. doi: 10.1097/OPX.0000000000001541.
9
Odysight: A Mobile Medical Application Designed for Remote Monitoring-A Prospective Study Comparison with Standard Clinical Eye Tests.奥德赛视力:一款用于远程监测的移动医疗应用程序——与标准临床眼科检查的前瞻性研究比较
Ophthalmol Ther. 2019 Sep;8(3):461-476. doi: 10.1007/s40123-019-0203-9. Epub 2019 Jul 25.
10
Home Monitoring of Retinal Sensitivity on a Tablet Device in Intermediate Age-Related Macular Degeneration.使用平板设备对中度年龄相关性黄斑变性患者进行视网膜敏感度的家庭监测
Transl Vis Sci Technol. 2018 Oct 29;7(5):32. doi: 10.1167/tvst.7.5.32. eCollection 2018 Sep.